Brain tumors, encompassing subtypes with distinct progression and risk profiles, are a serious public health concern. Magnetic resonance imaging (MRI) is the primary imaging modality for non-invasive assessment, providing the contrast and detail necessary for diagnosis, subtype classification, and individualized care planning. In this paper, we evaluate the capability of modern deep learning models to classify gliomas as high-grade (HGG) or low-grade (LGG) using reduced training data from MRI scans. Utilizing the BraTS 2019 best-slice dataset (2185 images in two classes, HGG and LGG) divided in two folders, training and testing, with different images obtained from different patients, we created subsets including 10%, 25%, 50%, 75%, and 100% of the dataset. Six deep learning architectures, DeiT3baseₚatch16₂24, Inceptionᵥ4, Xception41, ConvNextV2ₜiny, swinₜinyₚatch4window7₂24, and EfficientNetB0, were evaluated utilizing three-fold cross-validation (k = 3) and increasingly large training datasets. Explainability was assessed using Grad-CAM. With 25% of the training data, DeiT3baseₚatch16₂24 achieved an accuracy of 99. 401% and an F1-Score of 99. 403%. Under the same conditions, Inceptionᵥ4 achieved an accuracy of 99. 212% and a F1-Score of 99. 222%. Considering how the models performed across both data subsets and their compute demands, Inceptionᵥ4 struck the best balance for MRI-based glioma classification. Both convolutional networks and vision transformers achieved superior discrimination between HGGs and LGGs, even under data-limited conditions. Architectural disparities became increasingly apparent as training data diminished, highlighting unique inductive biases and efficiency characteristics. Even with a relatively limited amount of training data, current deep learning (DL) methods can achieve reliable performance in classifying gliomas from MRI scans. Among the architectures evaluated, Inceptionᵥ4 offered the most consistent balance between accuracy, F1-Score, and computational cost, making it a strong candidate for integration into MRI-based clinical workflows.
Gómez-Guzmán et al. (Mon,) studied this question.